Leber A, Hontecillas R, Tubau-Juni N, Lichtiger S, et al. WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS. Inflamm Bowel Dis 2022;28.
PMID: 35104848